Cargando…

Antiparkinson Prodrugs

Parkinson’s disease (PD) is a progressive, neurodegenerative disorder which involves the loss of dopaminergic neurons of the substantia nigra pars compacta. Current therapy is essentially symptomatic, and L-Dopa (LD), the direct precursor of dopamine (DA), is the treatment of choice in more advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Stefano, Antonio, Sozio, Piera, Cerasa, Laura Serafina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244951/ https://www.ncbi.nlm.nih.gov/pubmed/18259129 http://dx.doi.org/10.3390/molecules13010046

Ejemplares similares

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

National Trends of Antiparkinsonism Treatment in Taiwan: 2004–2011
por: Liu, Weng-Ming, et al.
Publicado: (2016)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

An Analysis of the Activating System Including Its use for Screening Antiparkinson Drugs
por: Himwich, Harold E., et al.
Publicado: (1955)

A Case of Organophosphate Poisoning Inducing Parkinsonism which was Effectively Treated by Antiparkinson Drugs
por: Yanagawa, Youichi, et al.
Publicado: (2023)

Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study
por: Tsugawa, Jun, et al.
Publicado: (2015)

A Fatal Case of Neuroleptic Malignant Syndrome After Paralytic Bowel in a Patient Taking Antiparkinson Medication
por: Campa, Domenico, et al.
Publicado: (2016)

Carvacrol Prodrugs with Antimicrobial Activity Loaded on Clay Nanocomposites
por: Eusepi, Piera, et al.
Publicado: (2020)

Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease
por: Herrán, Enara, et al.
Publicado: (2014)

Prodrug Approach for Increasing Cellular Glutathione Levels
por: Cacciatore, Ivana, et al.
Publicado: (2010)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Antiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3
por: Sogawa, Chiharu, et al.
Publicado: (2020)

Prodrugs for Amines
por: Simplício, Ana L., et al.
Publicado: (2008)

Dendrimer Prodrugs
por: da Silva Santos, Soraya, et al.
Publicado: (2016)

Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
por: Najjar, Anas, et al.
Publicado: (2020)

Prodrugs in Cardiovascular Therapy
por: Sandros, Marinella G., et al.
Publicado: (2008)

Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016)

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)

Trends in hospital admission related to poisoning by, narcotics and psychodysleptics and poisoning by antiepileptic, sedative-hypnotic, and antiparkinsonism drugs in England and Wales between April 1999 and April 2020: An ecological study
por: Alwafi, Hassan
Publicado: (2023)

Prodrugs for the Treatment of Neglected Diseases
por: Chung, Man Chin, et al.
Publicado: (2008)

The Medicinal Chemistry of Imidazotetrazine Prodrugs
por: Moody, Catherine L., et al.
Publicado: (2014)

Amino Acids in the Development of Prodrugs
por: Vale, Nuno, et al.
Publicado: (2018)

The Dark Side: Photosensitizer Prodrugs
por: Sansaloni-Pastor, Sara, et al.
Publicado: (2019)

Recent Development of Prodrugs of Gemcitabine
por: Pandit, Bhoomika, et al.
Publicado: (2022)

Ocular prodrugs: Attributes and challenges
por: kour, Jagpreet, et al.
Publicado: (2021)

Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach
por: Pavan, Barbara, et al.
Publicado: (2008)

Carvacrol Codrugs: A New Approach in the Antimicrobial Plan
por: Cacciatore, Ivana, et al.
Publicado: (2015)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Application of Prodrugs to Inflammatory Diseases of the Gut
por: Oz, Helieh S., et al.
Publicado: (2008)

Glutathione Transferase (GST)-Activated Prodrugs
por: Ruzza, Paolo, et al.
Publicado: (2013)

Hydrogen sulfide prodrugs—a review
por: Zheng, Yueqin, et al.
Publicado: (2015)

Pro-Moieties of Antimicrobial Peptide Prodrugs
por: Forde, Eanna, et al.
Publicado: (2015)

Antibacterial Prodrugs to Overcome Bacterial Resistance
por: Jubeh, Buthaina, et al.
Publicado: (2020)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Nanoparticulation of Prodrug into Medicines for Cancer Therapy
por: Zhang, Yuezhou, et al.
Publicado: (2021)

Enzyme Models—From Catalysis to Prodrugs
por: Breijyeh, Zeinab, et al.
Publicado: (2021)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Prodrug Strategies for Enhancing the Percutaneous Absorption of Drugs
por: N’Da, David D.
Publicado: (2014)

Hypoxia-activated prodrugs and redox-responsive nanocarriers
por: Zeng, Yun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nh32enj2q0gb28e1ke8bv90ve7